Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of extra-fine particle HFA-QVAR versus coarse particle inhaled corticosteroids in smokers and ex-smokers with asthma
2012-005350-39Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Apr 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of beclomethasone, beclomethasone dipropionate and fluticasone in asthma (3 arms), sponsored by University Medical Center Groningen. Primary endpoint: PD20 small particle adenosine. Started Apr 2013; status: active.
02
Drugs
beclomethasonebeclomethasone dipropionatefluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on 2012-005350-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005350-39.